Literature DB >> 21986499

PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth.

Jianyu Liu1, Payton D Stevens, Xin Li, Micheal D Schmidt, Tianyan Gao.   

Abstract

PHLPP is a family of Ser/Thr protein phosphatases that contains PHLPP1 and PHLPP2 isoforms. We have shown previously that PHLPP functions as a tumor suppressor by negatively regulating Akt signaling in cancer cells. Here we report the identification of ribosomal protein S6 kinase 1 (S6K1) as a novel substrate of PHLPP. Overexpression of both PHLPP isoforms resulted in a decrease in S6K1 phosphorylation in cells, and this PHLPP-mediated dephosphorylation of S6K1 was independent of its ability to dephosphorylate Akt. Conversely, S6K1 phosphorylation was increased in cells depleted of PHLPP expression. Furthermore, we showed that the insulin receptor substrate 1 (IRS-1) expression and insulin-induced Akt phosphorylation were significantly decreased as the result of activation of the S6K-dependent negative feedback loop in PHLPP knockdown cells. Functionally, the phosphorylation of ribosomal protein S6 (rpS6) and the amount of phosphorylated rpS6 bound to the translation initiation complex were increased in PHLPP-knockdown cells. This correlated with increased cell size, protein content, and rate of cap-dependent translation. Taken together, our results demonstrate that loss of PHLPP expression activates the S6K-dependent negative feedback loop and that PHLPP is a novel player involved in regulating protein translation initiation and cell size via direct dephosphorylation of S6K1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21986499      PMCID: PMC3233022          DOI: 10.1128/MCB.05799-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

Review 1.  Ras, PI(3)K and mTOR signalling controls tumour cell growth.

Authors:  Reuben J Shaw; Lewis C Cantley
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

2.  mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.

Authors:  Marina K Holz; Bryan A Ballif; Steven P Gygi; John Blenis
Journal:  Cell       Date:  2005-11-18       Impact factor: 41.582

3.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

4.  Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis.

Authors:  Igor Ruvinsky; Nitzan Sharon; Tal Lerer; Hannah Cohen; Miri Stolovich-Rain; Tomer Nir; Yuval Dor; Philip Zisman; Oded Meyuhas
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 11.361

5.  Phosphorylation and activation of p70s6k by PDK1.

Authors:  N Pullen; P B Dennis; M Andjelkovic; A Dufner; S C Kozma; B A Hemmings; G Thomas
Journal:  Science       Date:  1998-01-30       Impact factor: 47.728

6.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

7.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.

Authors:  Ken Inoki; Yong Li; Tianquan Zhu; Jun Wu; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

8.  Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase.

Authors:  H Shima; M Pende; Y Chen; S Fumagalli; G Thomas; S C Kozma
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

9.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.

Authors:  Andrew R Tee; Diane C Fingar; Brendan D Manning; David J Kwiatkowski; Lewis C Cantley; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

Review 10.  Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis.

Authors:  Brendan D Manning
Journal:  J Cell Biol       Date:  2004-11-08       Impact factor: 10.539

View more
  43 in total

1.  Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.

Authors:  Noel A Warfel; Alexandra C Newton
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Suppression of survival signalling pathways by the phosphatase PHLPP.

Authors:  Audrey K O'Neill; Matthew J Niederst; Alexandra C Newton
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

Review 3.  Turning off AKT: PHLPP as a drug target.

Authors:  Alexandra C Newton; Lloyd C Trotman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

4.  PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy in vitro.

Authors:  Szu-Tsen Yeh; Cristina M Zambrano; Walter J Koch; Nicole H Purcell
Journal:  J Biol Chem       Date:  2018-04-08       Impact factor: 5.157

5.  PHLPP2 Downregulation Contributes to Lung Carcinogenesis Following B[a]P/B[a]PDE Exposure.

Authors:  Haishan Huang; Xiaofu Pan; Honglei Jin; Yang Li; Lin Zhang; Caili Yang; Pei Liu; Ya Liu; Lili Chen; Jingxia Li; Junlan Zhu; Xingruo Zeng; Kai Fu; Guorong Chen; Jimin Gao; Chuanshu Huang
Journal:  Clin Cancer Res       Date:  2015-05-14       Impact factor: 12.531

6.  FANCI is a negative regulator of Akt activation.

Authors:  Xiaoshan Zhang; Xiaoyan Lu; Shamima Akhter; Maria-Magdalena Georgescu; Randy J Legerski
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

7.  Transcription factor C/EBP-β induces tumor-suppressor phosphatase PHLPP2 through repression of the miR-17-92 cluster in differentiating AML cells.

Authors:  Y Yan; E A Hanse; K Stedman; J M Benson; X H Lowman; S Subramanian; A Kelekar
Journal:  Cell Death Differ       Date:  2016-02-12       Impact factor: 15.828

8.  Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.

Authors:  Xiaopeng Xiong; Xin Li; Yang-An Wen; Tianyan Gao
Journal:  J Biol Chem       Date:  2016-10-19       Impact factor: 5.157

Review 9.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

10.  Phlpp1 facilitates post-traumatic osteoarthritis and is induced by inflammation and promoter demethylation in human osteoarthritis.

Authors:  E W Bradley; L R Carpio; M E McGee-Lawrence; C Castillejo Becerra; D F Amanatullah; L E Ta; M Otero; M B Goldring; S Kakar; J J Westendorf
Journal:  Osteoarthritis Cartilage       Date:  2015-12-31       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.